Exogenous platelet-derived growth factor improves neurovascular unit recovery after spinal cord injury.

The blood-spinal cord barrier plays a vital role in recovery after spinal cord injury. The neurovascular unit concept emphasizes the relationship between nerves and vessels in the brain, while the effect of the blood-spinal cord barrier on the neurovascular unit is rarely reported in spinal cord injury studies. Mouse models of spinal cord injury were established by heavy object impact and then immediately injected with platelet-derived growth factor (80 µg/kg) at the injury site. Our results showed that after platelet-derived growth factor administration, spinal cord injury, neuronal apoptosis, and blood-spinal cord barrier permeability were reduced, excessive astrocyte proliferation and the autophagy-related apoptosis signaling pathway were inhibited, collagen synthesis was increased, and mouse locomotor function was improved. In vitro, human umbilical vein endothelial cells were established by exposure to 200 µM H2O2. At 2 hours prior to injury, in vitro cell models were treated with 5 ng/mL platelet-derived growth factor. Our results showed that expression of blood-spinal cord barrier-related proteins, including Occludin, Claudin 5, and ß-catenin, was significantly decreased and autophagy was significantly reduced. Additionally, the protective effects of platelet-derived growth factor could be reversed by intraperitoneal injection of 80 mg/kg chloroquine, an autophagy inhibitor, for 3 successive days prior to spinal cord injury. Our findings suggest that platelet-derived growth factor can promote endothelial cell repair by regulating autophagy, improve the function of the blood-spinal cord barrier, and promote the recovery of locomotor function post-spinal cord injury. Approval for animal experiments was obtained from the Animal Ethics Committee, Wenzhou Medical University, China (approval No. wydw2018-0043) in July 2018.

Growth factors-based therapeutic strategies and their underlying signaling mechanisms for peripheral nerve regeneration.

Peripheral nerve injury (PNI), one of the most common concerns following trauma, can result in a significant loss of sensory or motor function. Restoration of the injured nerves requires a complex cellular and molecular response to rebuild the functional axons so that they can accurately connect with their original targets. However, there is no optimized therapy for complete recovery after PNI. Supplementation with exogenous growth factors (GFs) is an emerging and versatile therapeutic strategy for promoting nerve regeneration and functional recovery. GFs activate the downstream targets of various signaling cascades through binding with their corresponding receptors to exert their multiple effects on neurorestoration and tissue regeneration. However, the simple administration of GFs is insufficient for reconstructing PNI due to their short half­life and rapid deactivation in body fluids. To overcome these shortcomings, several nerve conduits derived from biological tissue or synthetic materials have been developed. Their good biocompatibility and biofunctionality made them a suitable vehicle for the delivery of multiple GFs to support peripheral nerve regeneration. After repairing nerve defects, the controlled release of GFs from the conduit structures is able to continuously improve axonal regeneration and functional outcome. Thus, therapies with growth factor (GF) delivery systems have received increasing attention in recent years. Here, we mainly review the therapeutic capacity of GFs and their incorporation into nerve guides for repairing PNI. In addition, the possible receptors and signaling mechanisms of the GF family exerting their biological effects are also emphasized.

[The continuous trophic spectrum of food web in Dalian marine area, China.] / å¤§è¿žæµ·åŸŸé£Ÿç‰©ç½‘è¿žç»­è¥å »è°±.

This study analyzed the values of δ13C and δ15N by the application of stable isotope technique from the marine mammals (Phoca largha, Neophocaena asiaorientalis sunameri, Balaenoptera acutorostrata) and major biological species in Dalian marine area based on the animals collected due to stranding and death after bycatch from January, 2008 to June, 2017, and the fisheries resources investigation between autumn, 2016 and spring, 2017 in the same area. The trophic level was then calculated in order to establish the continuous trophic spectrum of the food web in Dalian marine area. The results showed that the value of δ15N ranged from 8.0‰ to 14.7‰ and the value of δ13C ranged from -21.1‰ to -16.7‰ of the food web in Dalian marine area. The major biological species could be categorized into three groups, namely primary consumer, secondary consumer and top predator. The analysis of δ15N revealed that the trophic level ranged from 2.63 to 4.59 for the major biological species. The trophic level of B. acutorostrata, N. asiaorientalis sunameri, P. largha, echinoderm, cephalopods, gastropod, bivalve, crustacean and fish were 3.16, 4.11, 4.25, 3.24-3.84, 3.81-3.93, 3.65-4.13, 2.63-3.15, 3.58-4.12 and 3.20-4.59, respectively. The characteristics of the trophic structure demonstrated that the primary consumer was bivalve, the secondary consumers were B. acutorostrata, cephalopods, Echinoderms, gastropod and crustacean, and top predators were N. asiaorientalis sunameri, P. largha and fish. The value of δ15N increased with the increase in the body length, indicating the feeding of N. asiaorientalis sunameri tended to be at a higher trophic level with the growth and feeding ability enhanced. This study established the continuous trophic spectrum of food web in Dalian marine area and would provide the information for the marine mammal and fisheries resources protection.